Good to see progress on some trials but in relation to GVHD "expected to commence" sounds a little ominous .... perhaps CYP are in fact waiting for another biotech's response from the FDA given how many times the trial has been postponed ?
Ann: Strategic Review of Cynata Clinical Development Portfolio, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 16.0¢ | $53.16K | 331.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 48629 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 12163 | 3 |
View Market Depth
| Last trade - 14.11pm 25/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |